Community/Retail

Despite signs that influenza activity is declining, overall activity remains elevated across most of the United States following this season’s peak in early February.

Officials with the FDA have issued a statement warning Consumers to be wary of unapproved products that claim to prevent, treat, or cure influenza.

We all make important interventions as pharmacists, but we don’t make front page headlines.

Through clinical and humanistic interventions, pharmacists can improve outcomes and lower costs for patients with diabetes.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Pre-exposure prophylaxis saves lives by reducing the risk of acquiring HIV, but the need for cost-saving is great.

March is MS awareness month, spotlighting this chronic, progressive disease that is growing in prevalence.

After the tragic death of his daughter, Emily, he has made it his life's work to reduce preventable medical errors.

The FDA approved ZTlido (lidocaine topical system) 1.8% for the treatment of pain associated with post-herpetic neuralgia (PHA), which is caused by shingles.

A recent pilot looked into whether using a personal robot in a patients home could prevent readmission rates for those recently hospitalized with COPD.

What if Google Maps was powered to help patients navigate to their appointments quicker? Can Uber be a solution for transportation? New research sheds some light on these possibilities.

There are a lot of options for food items sold in your pharmacy—here is a simple guide to help you pick the very best.

Pharmacists can submit photos and captions to be featured on social media.

Helping patients find healthy and safe alternatives is key to supporting them with living a healthy lifestyle and decreasing gastrointestinal symptoms, fatigue and inflammation associated with celiac disease.

As cost increases, patient adherence decreases among patients with multiple chronic conditions.

The latest DrugStats database list shows the medications with increasing numbers of prescriptions.

There have been multiple concerns levied about PBM tactics that have led plan sponsors and pharmacy stakeholders to push back.

With Apple eyeing up the EHR space, the rational movement to get patients data through their iPhones is just the next place to start.

Identifying the right ingredients for change can help patients reduce their disease risk, improve health and empower them to adapt positive behaviors.

We talk to pharmacists with fascinating side hustles.

There are many mistakes, pitfalls, and unknowns that pharmacists routinely fail to consider before transitioning to another job.

Kempharma introduces newly approved pain management drug and warns of risk for addiction.

Silly things happen in the Pharmacy

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The FDA approved this nebulized long-acting muscarinic antagonist in December 2017, and it is expected to be launched this spring.

Clarithromycin (Biaxin) may increase the risk of heart problems and death among patients with cardiovascular disease.

Pharmacists can help consumers make decisions on the best OTC options.

You have been working towards Match Day for a while, but once it is over where do you go next?